• Mar 03, 2025

ThredUp (NASDAQ:TDUP) Misses Q4 Sales Targets

Online fashion resale marketplace ThredUp (NASDAQ:TDUP) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 17.4% year on year to $67.27 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $68.5 million at the midpoint, or 4.7% above analysts’ estimates. Its GAAP loss of $0.19 per share was significantly below analysts’ consensus estimates.

  • Mar 03, 2025

Okta (NASDAQ:OKTA) Exceeds Q4 Expectations, Stock Jumps 11.2%

Identity management software maker Okta (OKTA) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 12.7% year on year to $682 million. Guidance for next quarter’s revenue was better than expected at $679 million at the midpoint, 1.3% above analysts’ estimates. Its non-GAAP profit of $0.78 per share was 6% above analysts’ consensus estimates.

  • Mar 03, 2025

Mexico’s Star Economy Dreams Crumble Under Donald Trump’s Tariff Threats

(Bloomberg) -- Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyHow Upzoning in Cambridge Broke the YIMBY MoldRemembering the Landscape Architect Who Embraced the CityNYC Office Buildings See Resurgence as Investors Pile Into BondsHong Kong Joins Global Stadium Race With New $4 Billion Sports ParkOnly a couple years ago, manufacturers were fighting for space to relocate their operations

  • Mar 03, 2025

Crypto Prices Sink on Trump Reserve Skepticism, Tariff Concerns

(Bloomberg) -- Euphoria in digital-asset markets stemming from Donald Trump’s plans for a strategic crypto reserve turned to skepticism on Monday, triggering early losses in cryptocurrencies that worsened throughout the day as investors braced for the US to impose 25% tariffs on Mexico and Canada.Most Read from BloombergCuts to Section 8 Housing Assistance Loom Amid HUD UncertaintyHow Upzoning in Cambridge Broke the YIMBY MoldRemembering the Landscape Architect Who Embraced the CityNYC Office Bu

  • Mar 03, 2025

Guardant Health’s (NASDAQ:GH) Q4: Beats On Revenue

Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 30.2% year on year to $201.8 million. Its GAAP loss of $0.90 per share was 12.4% below analysts’ consensus estimates.